Lurasidone Drug Profile

What is Lurasidone?

Lurasidone is an atypical antipsychotic medication belonging to the benzisothiazol class of drugs. It is primarily prescribed to treat schizophrenia and certain types of bipolar disorder. The medication works by affecting neurotransmitter activity in the brain to help reduce symptoms of psychosis and mood episodes.

Uses

Lurasidone is FDA-approved for several psychiatric conditions:

• Schizophrenia: Used to treat positive symptoms (hallucinations, delusions) and negative symptoms (social withdrawal, lack of motivation) in adults and adolescents aged 13-17
• Bipolar I disorder depression: Treats depressive episodes in bipolar disorder, either as monotherapy or in combination with lithium or valproate
• Bipolar depression in adolescents: Approved for treating bipolar depression in patients aged 10-17 years
• Maintenance therapy: May be used for long-term management to prevent relapse of psychotic or mood episodes

How it works

Lurasidone works by blocking specific receptors in the brain, particularly dopamine D2 and serotonin 5-HT2A receptors. By modulating the activity of these neurotransmitters, it helps restore the chemical balance that becomes disrupted in conditions like schizophrenia and bipolar disorder. The medication also has activity at other serotonin receptors, which may contribute to its effectiveness in treating depression and reducing certain side effects.

Side effects

Common side effects include:

Submit Your Paper

• Nausea and vomiting
• Drowsiness and sedation
• Movement disorders (tremor, muscle stiffness)
• Restlessness (akathisia)
• Dizziness
• Anxiety or agitation
• Insomnia
• Abdominal pain

Serious side effects to watch for:

• Neuroleptic malignant syndrome (fever, muscle rigidity, altered mental status)
• Tardive dyskinesia (involuntary repetitive movements)
• Severe allergic reactions
• Significant changes in blood sugar or cholesterol levels
• Suicidal thoughts, especially in young adults

Warnings and precautions

• Elderly patients with dementia: Increased risk of death; lurasidone is not approved for dementia-related psychosis
• Pregnancy and breastfeeding: Should only be used when potential benefits outweigh risks; can cause withdrawal symptoms in newborns
• Cardiovascular disease: May cause orthostatic hypotension and should be used cautiously in patients with heart conditions
• Kidney or liver impairment: Dose adjustments may be necessary; severe hepatic impairment requires avoiding the medication
• Seizure disorders: May lower seizure threshold; use with caution in patients with epilepsy or seizure history

Interactions

Lurasidone has several important drug interactions:

• Strong CYP3A4 inhibitors (ketoconazole, clarithromycin): Can significantly increase lurasidone levels, potentially causing toxicity
• Strong CYP3A4 inducers (rifampin, St. John’s wort): May reduce lurasidone effectiveness by lowering drug levels
• Central nervous system depressants (alcohol, benzodiazepines): Enhanced sedation and respiratory depression risk
• Antihypertensive medications: Increased risk of low blood pressure and dizziness
• QT-prolonging drugs (certain antibiotics, antiarrhythmics): May increase risk of dangerous heart rhythm abnormalities
• Grapefruit juice: Can increase lurasidone levels and should be avoided
• Lithium: May increase risk of movement disorders when used together
• Diabetes medications: Lurasidone may affect blood sugar control, requiring monitoring

Check interactions with the GMJ Interaction Checker

Dosage

Lurasidone dosing varies based on the condition being treated and individual patient factors. For schizophrenia in adults, the typical starting dose is 40 mg once daily, with a usual range of 40-80 mg daily and a maximum of 160 mg daily. For bipolar depression, doses typically range from 20-120 mg daily. The medication should be taken with food (at least 350 calories) to ensure proper absorption. Adolescent dosing is generally lower, starting at 20 mg daily. Dose adjustments may be necessary for patients with kidney impairment or when used with certain other medications. All dosing decisions should be individualized and determined by a qualified healthcare provider based on the patient’s specific medical condition and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).